Brief: Unicycive Announces Q3 2024 Financial Results And Provides Business Update
Nov 13 (Reuters) - Unicycive Therapeutics Inc UNCY.O :
* UNICYCIVE ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS
AND
PROVIDES BUSINESS UPDATE
* : QTRLY LOSS PER SHARE $0.05
* Q3 EARNINGS PER SHARE VIEW $-0.15 -- LSEG IBES DATA
Source text: urn:newsml:reuters.com:*:nGNX5cJmcN
Further company coverage: UNCY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Unicycive Therapeutics
See all newsBrief: Unicycive Therapeutics Appoints Meredith Manning To Board Of Directors
Brief: Unicycive Therapeutics Announces Resubmission Of New Drug Application For Oxylanthanum Carbonate
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
Unicycive rises on narrower quarterly loss